Google DeepMind’s London AI drug spinout eyes $50bn valuation

London-based AI drug discovery firm, Isomorphic Labs, is reportedly seeking a valuation of up to $50bn (£37bn) in fresh funding talks, just five months after raising $2.1bn from investors. The Google DeepMind spinout, led by Nobel Prize-winning scientist Sir Demis Hassabis, is in early discussions to raise new capital at a valuation of at least $40bn, according to Bloomberg. The figure could climb as high as $50bn, although negotiations remain early and no agreement has…